HIKAL
Back to All Ratios
|
HIKAL Last 5 Year Pre Tax Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Pre Tax Margin(%) | 5.35 | 5.21 | 11.25 | 12.00 | 8.40 |
What is the latest Pre Tax Margin ratio of HIKAL ?
Year | Pre Tax Margin |
---|---|
Mar2024 | 5.35 |
Mar2023 | 5.21 |
Mar2022 | 11.25 |
Mar2021 | 12.00 |
Mar2020 | 8.40 |
How is Pre Tax Margin of HIKAL Trending?
Years | Pre Tax Margin | % Change | |
---|---|---|---|
Mar2024 | 5.35 | 2.69 | |
Mar2023 | 5.21 | -53.69 | |
Mar2022 | 11.25 | -6.25 | |
Mar2021 | 12 | 42.86 | |
Mar2020 | 8.4 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Pre Tax Margin ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,318.0 Cr | 5.2% | -16.8% | -22% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -2.2% | -8.3% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -1.1% | -7.3% | 21.6% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.7% | 1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -0.5% | -4.2% | 4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.5% | -1.1% | -7.7% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | 5.2% |
-16.8% |
-22% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses